Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1273087 NEW YORK, NY
Back to TMO Full portfolio

Position in TMO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$34,749,204
+$4,464,830 QoQ
Shares Held
70,696
+35.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Mar 31, 2026
CallValue
$24,232,429
CallShares
49,300
PutValue
$65,520,949
PutShares
133,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $798,894,531 across 31 Diagnostics & Research names. TMO ranks #7 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRL
Charles River Laboratories International, Inc.
 934,045 $161,122,762
2 GH
Guardant Health, Inc.
 921,395 $85,109,256
3 A
Agilent Technologies, Inc.
 686,546 $78,252,513
4 WAT
Waters Corp /De/
 185,168 $55,143,030
5 IQV
Iqvia Holdings Inc.
 268,185 $45,736,269
6 IDXX
Idexx Laboratories Inc /De
 70,446 $39,582,902
7 TMO
Thermo Fisher Scientific Inc.
This page 		70,696 $34,749,204
8 DHR
Danaher Corp /De/
 182,825 $34,663,620

All Filings in TMO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $65,520,949 133,300
2026-03-31 $34,749,204 70,696
2026-03-31 $24,232,429 49,300
2025-12-31 $70,403,175 121,500
2025-12-31 $30,284,374 52,264
2025-12-31 $46,703,670 80,600
2025-09-30 $241,099,076 497,091
2025-09-30 $43,603,298 89,900
2025-09-30 $18,915,780 39,000
2025-06-30 $126,097,654 310,999
2025-06-30 $21,448,834 52,900
2025-06-30 $43,911,318 108,300
2025-03-31 $35,976,480 72,300
2025-03-31 $93,785,160 188,475
2025-03-31 $62,399,040 125,400
2024-12-31 $92,809,032 178,400
2024-12-31 $178,116,867 342,381
2024-12-31 $37,248,468 71,600
2024-09-30 $75,759,979 122,476
2024-09-30 $225,901,764 365,200
2024-09-30 $30,186,216 48,800
2024-06-30 $312,677,813 565,421
2024-06-30 $61,714,800 111,600
2024-06-30 $190,066,100 343,700
2024-03-31 $133,678,300 230,000
2024-03-31 $22,700,318 39,057
2024-03-31 $60,329,598 103,800
2023-12-31 $87,739,587 165,300
2023-12-31 $69,305,250 130,570
2023-12-31 $95,436,042 179,800
2023-09-30 $248,104,793 490,161
2023-09-30 $73,344,033 144,900
2023-09-30 $54,666,360 108,000
2023-06-30 $46,070,525 88,300
2023-06-30 $44,296,575 84,900
2023-06-30 $142,301,573 272,739
2023-03-31 $16,368,908 28,400
2023-03-31 $47,528,046 82,461
2023-03-31 $21,498,601 37,300
2022-12-31 $316,096 574
2022-12-31 $82,768,707 150,300
2022-12-31 $93,341,955 169,500
2022-09-30 $13,947,725 27,500
2022-09-30 $166,814,791 328,900
2022-09-30 $10,185,896 20,083
2022-06-30 $39,654,007 72,990
2022-06-30 $7,877,560 14,500
2022-06-30 $146,250,976 269,200
2022-03-31 $44,887,037 75,996
2022-03-31 $158,943,915 269,100

Report a Problem

Category
Description
Email (optional, for follow-up)